Immunotherapeutic applications of CpG-containing oligodeoxynucleotides
D M Klinman1, K J Ishii, M Gursel
1Section of Retroviral Research, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
Drug News & Perspectives
|August 26, 2003
Summary
Unmethylated CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides (ODN) activate the immune system. These CpG ODN are explored for therapeutic uses, including immune adjuvants, antiallergy treatments, and host protection.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Bacterial DNA and synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs are potent stimulators of the mammalian immune system.
- This stimulation triggers a rapid innate immune response, involving polyreactive IgM, cytokines, and chemokines.
Purpose of the Study:
- To explore the therapeutic potential of CpG ODN.
- To investigate their role as immune adjuvants, antiallergic agents, and immunoprotective compounds.
Main Methods:
- Direct stimulation of lymphocytes, natural killer cells, and antigen-presenting cells (macrophages, dendritic cells) by CpG ODN.
- Evaluation of immune response modulation, including Th1/Th2 balance and cytokine production.
Main Results:
- CpG ODN elicit a strong interferon gamma-dominated Th1 response.
- CpG ODN demonstrate potential in blocking Th2-dependent allergies.
- The innate immune response induced by CpG ODN offers protection against pathogens.
Conclusions:
- CpG ODN represent a promising class of therapeutic agents due to their ability to modulate innate and adaptive immunity.
- Further research into CpG ODN applications in vaccines, allergy treatment, and infectious disease prevention is warranted.
More Related Videos
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...